Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 21, 1999New England Journal of MedicineOpen Access

Lamivudine as Initial Treatment for Chronic Hepatitis B in the United States

View Full Paper
Ask AI
Bookmark
Share

Authors

JDJules L. DienstagGoethe University FrankfurtESEugene R. SchiffBoston UniversityTWTeresa L. WrightCalifornia State University, Long Beach

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Dienstag et al. (1999) studied this question.

synapsesocial.com/papers/6a828f92979d337bd44404bchttps://doi.org/10.1056/nejm199910213411702
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy1998 · 375 citations
  2. 2Histopathology of Hepatitis C Virus Infection1995 · 263 citations
  3. 3Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†1981 · 3,566 citations
  4. 4A One-Year Trial of Lamivudine for Chronic Hepatitis B1998 · 1,762 citations
  5. 5Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B1993 · 997 citations